Efavirenz; lamivudine; tenofovir disoproxil fumarate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for efavirenz; lamivudine; tenofovir disoproxil fumarate and what is the scope of patent protection?
Efavirenz; lamivudine; tenofovir disoproxil fumarate
is the generic ingredient in three branded drugs marketed by Aurobindo Pharma Ltd, Laurus, Macleods Pharms Ltd, Mylan Labs Ltd, and Mylan, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Two suppliers are listed for this compound.
Summary for efavirenz; lamivudine; tenofovir disoproxil fumarate
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 5 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 2 |
Clinical Trials: | 28 |
DailyMed Link: | efavirenz; lamivudine; tenofovir disoproxil fumarate at DailyMed |
Recent Clinical Trials for efavirenz; lamivudine; tenofovir disoproxil fumarate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | N/A |
Professor Francois Venter | Phase 3 |
Yu-Jay Corp. | Phase 3 |
See all efavirenz; lamivudine; tenofovir disoproxil fumarate clinical trials